Seema Venkatachalam
Chgo, ILNPI 1790712776
Payments from drug & device makers
$2,987in general payments, 2019–2025
Across 147 payments — averaging $20.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$851
- Mayne Pharma Commercial LLC$236
- Exeltis, USA Inc.$232
- Hologic Sales And Service, LLC$185
- Avion Pharmaceuticals$174
- Coopersurgical, Inc.$153
- plus $1K from 18 others
What the payments were for
- Food & beverage$2,96899%
- Education$191%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
19
20
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 41 | $851 |
| Mayne Pharma Commercial LLC | 12 | $236 |
| Exeltis, USA Inc. | 12 | $232 |
| Hologic Sales And Service, LLC | 10 | $185 |
| Avion Pharmaceuticals | 7 | $174 |
| Coopersurgical, Inc. | 9 | $153 |
| Myovant Sciences Inc. | 5 | $142 |
| Organon | 10 | $141 |
| Channel Medsystems, Inc. | 3 | $122 |
| Bayer | 5 | $109 |
| Merck | 5 | $92 |
| Therapeuticsmd, Inc. | 5 | $86 |
| Millicent US Inc | 4 | $84 |
| Exact Sciences | 4 | $75 |
| Astellas Pharma US Inc | 3 | $75 |
| Biogen | 3 | $57 |
| Novo Nordisk | 2 | $41 |
| Sumitomo Pharma America, Inc. | 1 | $29 |
| Pfizer | 1 | $23 |
| AMAG Pharmaceuticals, Inc. | 1 | $19 |
| Vertex | 1 | $18 |
| Duchesnay USA Incorporated | 1 | $17 |
| Scynexis, Inc. | 1 | $14 |
| Mission Pharmacal Company | 1 | $12 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.